Publication | Closed Access

Noninvasive identification of HER2-low-positive status by MRI-based deep learning radiomics predicts the disease-free survival of patients with breast cancer

Breast OncologyEngineeringMedical ImagingMedical Image ComputingHer2-low-positive StatusBreast ImagingBreast CancerDisease-free SurvivalRadiomicsDeep LearningOncologyRadiation OncologyDiagnostic ImagingRadiologyHealth Sciences